Analysts' Actions -- Abbott Labs, Garmin, Nordson, NetApp and More
RATINGS CHANGES
Abbott Labs (ABT) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABT.
Garmin (GRMN) was downgraded to sell from neutral at Goldman Sachs. $46 price target. Fitness segment growth is decelerating, Goldman said.
Jack Henry (JKHY) was downgraded to perform from outperform at Oppenheimer. The valuation is less attractive, with shares trading at 28x earnings, Oppenheimer said.
TheStreet Recommends
Nordson (NDSN) was downgraded to perform from outperform at Oppenheimer. The valuation is less attractive, with the stock trading at 20x expected 2017 earnings, Oppenheimer said.
NetApp (NTAP) was upgraded to neutral from sell at Goldman Sacks. $32 price target. The valuation is more attractive, as revenue appears to be stabilizing, Goldman said.
Sanofi (SNY) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: SNY.
Tutor Perini (TPC) was upgraded to buy from neutral at MKM Partners. $28 price target. The company will likely pay down a significant amount of debt in the coming quarters and see a larger project pipeline, MKM said.
This article was written by a staff member of TheStreet.
